Skip to main content


We're creating a new version of this page. See preview

Volume 12 Supplement 1

Beyond the Genome 2011

  • Poster presentation
  • Open Access

The mutation spectrum in Indian patients with Gaucher disease

  • 1,
  • 2,
  • 2,
  • 1,
  • 1 and
  • 1
Genome Biology201112 (Suppl 1) :P26

  • Published:


  • Informed Consent
  • Clinical Manifestation
  • Biochemical Analysis
  • Initial Screening
  • Indian Patient

Gaucher disease is the most common lysosomal storage disorder. It results from an inherited deficiency of the enzyme glucocerebrosidase (GBA); accumulation of the substrate of this enzyme has many clinical manifestations. Since the discovery of the GBA gene, more than 200 mutations have been identified, but only a handful of mutations are recurrent (L444P, N370S, IVS2, D409H and 55Del). To determine the spectrum of mutations in the Indian population, we performed mutational screening in children with Gaucher disease.

Twenty-four patients from twenty families were enrolled in this study, after written informed consent was obtained. The diagnosis of Gaucher disease was based on mandatory clinical and biochemical analysis. An initial screening for five common mutations was carried out using PCR-RFLP. Patients who were negative for common mutations were screened by sequencing exons 9 to 11 (a mutation hotspot region) [1].

We identified common mutations (L444P, N370S, IVS2 and D409H [2], and 55Del [3]) in approximately 50% of the patients. L444P (c.1448T>C) was the most frequently identified, followed by D409H in our patients. Western data shows that N370S is the most common mutation in Romanian patients [4]. One polymorphism (E340K) was identified in two patients who were compound heterozygotes for A456P/R463C and S237F/A269P, respectively. Our data highlight the spectrum of mutations that lead to Gaucher disease in the Indian population.

Authors’ Affiliations

Genetics Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
Yale University School of Medicine, New Haven, USA


  1. Hatton CE, Cooper A, Whitehouse C, Wraith JE: Mutation analysis in 46 British and Irish patients with Gaucher’s disease. Arch Dis Child. 1997, 77: 17-22. 10.1136/adc.77.1.17.PubMedPubMed CentralView ArticleGoogle Scholar
  2. Rozenberg R, Araujo FT, Fox DC, Aranda P, Nonino A, Micheletti C, Martins AM, Cravo R, Sobreira E, Pereisa LV: High frequency of mutation G377S in Brazilian type 3 Gaucher disease patients. Braz J Med Biol Res. 2006, 39: 1171-1179. 10.1590/S0100-879X2006000900004.PubMedView ArticleGoogle Scholar
  3. Tayebi N, Stern H, Dymarskaia I, Herman J, Sidransky E: 55-Base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles. Am J Med Genet. 1996, 66: 316-319. 10.1002/(SICI)1096-8628(19961218)66:3<316::AID-AJMG15>3.0.CO;2-P.PubMedView ArticleGoogle Scholar
  4. Drugan C, Procopciuc L, Jebeleanu G, Grigorescu-Sido P, Dussau J, Poenaru L, Caillaud C: Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations. Eur J Hum Genet. 2002, 10: 511-515. 10.1038/sj.ejhg.5200845.PubMedView ArticleGoogle Scholar


© Bisariya et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.